These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36254386)

  • 1. Correlation between serum cystatin C level and renal microvascular perfusion assessed by contrast-enhanced ultrasound in patients with diabetic kidney disease.
    Zhao P; Li N; Lin L; Li Q; Wang Y; Luo Y
    Ren Fail; 2022 Dec; 44(1):1732-1740. PubMed ID: 36254386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
    Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
    J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound with SonoVue could accurately assess the renal microvascular perfusion in diabetic kidney damage.
    Ma F; Cang Y; Zhao B; Liu Y; Wang C; Liu B; Wu T; Song Y; Peng A
    Nephrol Dial Transplant; 2012 Jul; 27(7):2891-8. PubMed ID: 22532616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease.
    Christiadi D; Simpson C; O'brien K; Taylor K; Luxton G; Rossleigh M; Erlich J; Endre ZH
    Nephrol Dial Transplant; 2022 May; 37(6):1118-1124. PubMed ID: 34043011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Contrast-enhanced Ultrasound in the Evaluation of Chronic Kidney Disease.
    Han BH; Park SB
    Curr Med Imaging; 2021; 17(8):1003-1009. PubMed ID: 33504313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of contrast-enhanced ultrasonography (CEUS) in evaluating renal microvascular perfusion in pediatric patients.
    Zhang W; Yi H; Cai B; He Y; Huang S; Zhang Y
    BMC Med Imaging; 2022 Nov; 22(1):194. PubMed ID: 36357841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Renal Microperfusion in Diabetic Patients With Kidney Injury by Contrast-Enhanced Ultrasound.
    Wang Y; Li N; Tian X; Lin L; Liang S; Zhao P; Dong Z; Wang Q; Li Q; Tang J; Luo Y
    J Ultrasound Med; 2021 Jul; 40(7):1361-1368. PubMed ID: 33035374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal elasticity and perfusion changes on ultrasonography in an early-stage diabetic rat model.
    Li Y; Liu ZS; Wei R; Liu ZW; Guo LX; Ren JH
    Quant Imaging Med Surg; 2023 Dec; 13(12):7667-7679. PubMed ID: 38106289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of glomerular filtration rate using cystatin C in diabetic patients analysed by multiple factors including tubular function.
    Zhang PP; Zhan JF; Xie HL; Li LS; Liu ZH
    J Int Med Res; 2010; 38(2):473-83. PubMed ID: 20515562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
    Andersen TB
    Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
    Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
    Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.
    Ji F; Zhang S; Jiang X; Xu Y; Chen Z; Fan Y; Wang W
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27726176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease.
    Yashiro M; Kamata T; Segawa H; Kadoya Y; Murakami T; Muso E
    Clin Exp Nephrol; 2009 Dec; 13(6):598-604. PubMed ID: 19585181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
    Sinna MM; Altaf FMN; Mosa OF
    Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Contrast-Enhanced Ultrasound to Study Relationship between Serum Uric Acid and Renal Microvascular Perfusion in Diabetic Kidney Disease.
    Wang L; Cheng JF; Sun LP; Song YX; Guo LH; Xu JM; Wu TF; Mohan C; Peng A; Xu HX; Liu XY
    Biomed Res Int; 2015; 2015():732317. PubMed ID: 26106613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease].
    Martín MV; Barroso S; Herráez O; de Sande F; Caravaca F
    Nefrologia; 2006; 26(4):433-8. PubMed ID: 17058854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.